Prof. Peter Collins, Prof. Giuseppe Mancia, Prof. Carolyn Lam, Dr. Choo Gim Hooi, 20170712103633
Coronary artery disease (CAD) is the leading cause of death worldwide
and is expected to remain so for the foreseeable future due to both the
ageing population and the increasing prevalence of risk factors such as
hypertension, dyslipidaemia, and diabetes. CAD is also the primary risk
factor in the development of heart failure (HF). At the 2nd Asia Pacific
CardioConnect Meeting in Hong Kong sponsored by Menarini, a group of
international and regional experts discussed current strategies for
managing stable CAD and HF and highlighted areas where patient outcomes
may be improved.
During a recent continuing medical education programme sponsored by Hospira, Professor Yahya Shehabi spoke on the various strategies to ensure patient comfort and safety in the care of critically ill patients.
At the recent launch of Nurofen® Express by Reckitt Benckiser Malaysia, Ms Joyce McSwan spoke on the importance of managing tension-type headache (TTH), highlighting the roles of drug and non-drug approaches in improving treatment outcomes.
Hypertension management has significantly evolved over the past decades. New treatment strategies are constantly being developed to manage the condition. At a recent Abbott-sponsored lunch symposium held during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension in Kuala Lumpur, an expert from Italy provided some insights into the modern treatment of hypertension, with particular interest in the use of calcium channel blockers (CCBs).
The University of Science, Malaysia (USM) team, led by Professor Dr Lee Yeong Yeh was recognized for its outstanding research submission that links poor hygiene practices in flood-affected areas to the increased risk in communicable intestinal infections in parts of Malaysia.
Recently in the news, there were reports of outbreaks of avian flu and influenza-like illness (ILI) in Kelantan and Perak, respectively. To help readers gain a better understanding of influenza, MIMS Doctor sat down with Associate Professor Dr Pang Yong Kek to understand how common is influenza in Malaysia and preventive strategies against it.
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
In an exclusive interview with MIMS Doctor, Dr Yong Junina Fadzil, a consultant paediatrician and paediatric cardiologist at Klinik Pakar Kanak-Kanak Junina shared her perspectives on the roles of balanced nutrition and parental influence in child development.
An 8-week regimen of sofosbuvir-velpatasvir-voxilaprevir combination is not noninferior to a 12-week regimen of sofosbuvir-velpatasvir for patients with chronic hepatitis C virus (HCV) infection, report two recent phase 3 open-label trials.
The additional use of intermittent low-energy diet (LED) or daily meal replacements after a mean 10-percent weight loss and 1-year maintenance effectively maintains weight loss in obese patients with knee osteoarthritis for 3 years, according to a recent study.
A recent study has found that food bolus impaction or strictures predict most episodes of oesophageal perforation, a rare but serious complication of eosinophilic esophagitis (EoE) that occurs in about 2 percent of cases. This suggests that patients with fibrostenotic disease due to longer duration of symptoms are at increased risk.